Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review The ...

A recent update of this original risk stratification scheme addressed not only recurrence, but also prostate-cancer-specific mortality, in an expanded multicenter database of over 7,000 patients ...

Prostate cancer is the most common cancer among men ... to assess the impact of these tissue-based genomic tests on risk stratification and treatment decisions for localized prostate cancer.

THURSDAY, Jan. 9, 2025 (HealthDay News) -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate-specific membrane antigen-positron ...

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

(HealthDay News) — For patients with localized prostate cancer (PCa), tissue-based genomic ... Prostate Score (GPS), and Prolaris GCs on risk stratification and patient-clinician decisions ...

Most patients had one or more metastases when they were diagnosed with prostate cancer. Overall, 9 (11.4 %) and 17 (21.5 %) patients underwent radical prostatectomy and radiation therapy ...